Fitfit sold women's shoes designed for bunions — a niche with a real customer — and grew fast after its founding in 2018, reaching more than 50 stores nationwide and about ¥3.9 billion in sales in the fiscal year ending July 2019.
COVID closed the stores, and shoe demand stayed weak afterward. Performance deteriorated, and the company split: a new fitfit was created to carry the business on, while the old company — renamed Setagaya Shouji — stayed behind as a liquidation-purpose company holding the debts.
The Tokyo District Court issued a special liquidation commencement order on 14 April 2026, with liabilities estimated at about ¥3 billion.
Split the company: a new fitfit kept the stores trading while the old shell, renamed Setagaya Shouji, took the ¥3B debts into special liquidation.
Expansion before the market was proven: 50 stores within about a year of founding assumed demand that COVID then removed overnight.
One niche, no second act: bunion shoes served a specific customer, and when store traffic and shoe demand fell together, there was no other business to lean on.
The debt outlived the business: the company split kept the stores alive under a new entity while the old shell took the ¥3B — the failure was carried, not cured.
The business can survive while the company dies: FitFit's stores were split into a new entity to keep trading, and the old shell still carries ¥3B of debts — the failure was hived off, not solved.
The Tokyo District Court issued a special liquidation order for Setagaya Shouji, formerly fitfit, on 14 April 2026, with liabilities of about ¥3 billion. The company, founded in 2018, sold bunion-friendly women's shoes and expanded to more than 50 stores, with sales of about ¥3.9 billion in fiscal year ending July 2019. COVID-19 store closures and the later decline in shoe demand worsened performance; to continue operations, a new fitfit was established through a company split, while the old company renamed itself Setagaya Shouji and handled the winding-up. Reported 1 May 2026.
FOLLOW THE EVIDENCE